12:00 AM
 | 
Apr 18, 2005
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Kos, Barr Laboratories Inc. sales and marketing update

KOSP and BRL's Duramed Pharmaceuticals subsidiary will co-promote KOSP's Niaspan extended-release niacin and Advicor extended-release niacin/lovastatin cholesterol drugs. Duramed will be eligible...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >